ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Dishman Carbogen Amcis Earnings Call: Key Takeaways

Dishman Carbogen Amcis reported strong FY26 performance with revenue up 8.1% and EBITDA margins expanding to 19.3%. Growth is driven by CDMO and Vitamin D analogue segments.

Highlights
Revenue growth8.1% YoY for FY26.
MarginsFY26 EBITDA margin improved to 19.3% from 17.3% YoY.
Demand visibilityStrong basket of 10 molecules in Late Phase III development.

Growth

FY26 Net Revenue grew 8.1% YoY to ₹29,319mn; PAT surged to ₹974.5mn from ₹32.4mn in FY25.

Outlook

Capex of CHF 22.4mn added; focusing on capacity utilization and late-phase III molecules (10 in basket).

Risks

EBITDA margin compression in CDMO segment for Q4 due to high-base effect of development revenue.

Source

Earnings Call filed with BSE, NSE: DCAL. Summary written with AI assistance from the document.

Read the document ↗

Dishman Carbogen Amcis Ltd: key numbers

Share price
₹175.00
Market cap
₹2,744 Cr
Revenue (annual)
₹2,932 Cr
Net profit (annual)
₹97.45 Cr
P/E (TTM)
169.8×Sector 43.8×
Promoter holding
59.32%+0.00% QoQ
FII holding
6.96%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Dishman Carbogen Amcis Ltd

All →